Rallybio Corp (RLYB) Live Share Price, Invest From India

Rallybio Corp Stock Performance

as on March 26, 2026 at 3:08 am IST

Day's Low
Day's High
$8.76
Day's Price Range
$9.00
$8.75
-0.11%
Downside
2.86%
Upside
52 Week's Low
52 Week's High
$1.76
52-Week Price Range
$11.49
$8.75
79.88%
Downside
31.31%
Upside

Rallybio Corp share price movements today

Previous Close: $8.67
Open: $8.96
Volume: 162.5K
Day's Low - High: $8.76 - $9.00
52 Week Low - High: $1.76 - $11.49

Rallybio Corp Historical Returns

1 Month Return: + 48.97 %
3 Month Return: + 48.13 %
1 Year Return: + 64.3 %
3 Year Return: -76.18 %
5 Year Return: 0 %

Rallybio Corp Stock Fundamentals & Key Indicators

Check Rallybio Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$48.2M

EPS (TTM)

-5.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-31.3M

Revenue (TTM)

858.0K

Profit Margin

0.00%

Return On Equity TTM

-15.01%

Rallybio Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rallybio Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Rallybio Corp	BUY	$48.2M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$40.7B	127.78%	131.61	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$114.6B	111.25%	29.42	32.94%
Beone Medicines Ltd	NA	$31.6B	NA	111.23	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$77.9B	60.03%	17.76	31.41%

Stock Returns calculator for Rallybio Corp Stock including INR - Dollar returns

The Rallybio Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Rallybio Corp investment value today

Current value as on today

₹1,75,681

Returns

₹75,681

(+75.68%)

Returns from Rallybio Corp Stock

₹65,720 (+65.72%)

Dollar Returns*

₹9,961 (+9.96%)

Analyst Recommendation on Rallybio Corp Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Rallybio Corp. Average target price of $8

Rallybio Corp Share Price Target

Get share price movements and forecasts by analysts on Rallybio Corp.

What analysts predicted

-9.38%DOWNSIDE

Target Price

Current Price

$8.75

Analyzed by

12 Analysts

Target

$8.00

Rallybio Corp target price $8, a slight downside of -9.38% compared to current price of $8.75. According to 12 analysts rating.

Rallybio Corp Stock’s Investor Sentiment and Interest

Search interest for Rallybio Corp Stock has increased by 285% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 23, 2026 to March 25, 2026

Change:285% versus previous 30 day period

Rallybio Corp Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	0	-	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-19	-21	-19	-17	-12	-11	-9	-10	-6	-6
EBITDA	-19	-21	-19	-17	-12	-11	-9	-10	-6	-6
Interest Expense	-	1	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-18	-20	-19	-16	-11	-11	-9	-9	16	-5
Income Tax Expense	0	0	0	0	-	0	-	0	-	-
Net Income	-18	-20	-19	-16	-11	-11	-9	-9	16	-5
Net Profit Margin	0.00%	-8878.07%	0.00%	-5430.10%	-3834.78%	-29063.16%	-4452.36%	-4576.89%	7554.72%	-2636.04%

Rallybio Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	0	0
Gross Profit	0	0	0	0	0	0	0
Operating Income	-17	-25	-45	-67	-78	-60	-28
EBITDA	-17	-25	-45	-67	-78	-60	-27
Interest Expense	0	0	0	2	-	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-17	-26	-47	-67	-74	-57	-8
Income Tax Expense	0	0	1	-1	-2	-2	-
Net Income	-17	-26	-47	-66	-74	-57	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-9084.12%	-1046.39%

Rallybio Corp Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-20	-19	-16	-11	-11	-9	-9	16	-5
Operating Cash Flow	-11	-15	-10	-13	-9	-10	-8	-6	-4
Investing Cash Flow	16	10	2	22	-1	11	3	29	3
Financing Cash Flow	0	-	5	0	0	-	0	-	0
Change in Cash	5	-5	-2	8	-11	0	-5	22	0

Rallybio Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-26	-47	-66	-74	-57	-8
Operating Cash Flow	-22	-45	-57	-60	-49	-29
Investing Cash Flow	-2	-2	-112	27	33	47
Financing Cash Flow	144	82	51	0	5	0
Change in Cash	120	35	-118	-32	-10	17

Global Institutional Holdings in Rallybio Corp

Funds	Holdings
AJU IB Investment Co Ltd	14.27%
Mariner Wealth Advisors LLC	7.65%
Acadian Asset Management LLC	1.71%
Geode Capital Management, LLC	4.63%
New Leaf Venture Partners, L.L.C.	62.42%

See all

Insights on Rallybio Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, RLYB stock has moved up by 49.0%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, RLYB has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Rallybio Corp has experienced a drawdown of -76.2%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 66.7%

About Rallybio Corp

rallybio is a privately-held early-stage biotechnology company incorporated in january 2018. our ambition is to create a world-leading biotechnology organization that transforms the lives of patients with devastating disease, built around people with an outstanding track record in pharmaceutical research and development. we will work on highly-promising drug candidates that have strong biological rationales and that can be addressed using the well-validated therapeutic modalities of small molecules, engineered proteins, and antibodies. rallybio’s founders are seasoned leaders from the biopharma industry with a wide breadth of research, development, and financial experience. the company is based in farmington, ct, at the university of connecticut’s technology incubation program. we are assembling a small team of people with an outstanding track record in pharmaceutical research and development to search for and evaluate assets using a series of robust clinical and commercial filters tha

Organisation	Rallybio Corp
Headquarters	234 Church Street, New Haven, CT, United States, 06510
CEO	Dr. Stephen Uden M.D., MBBS
E-voting on shares	Click here to vote

Key Management of Rallybio Corp

Name	Title
Dr. Martin W. MacKay Ph.D.	Co-Founder & Chairman
Dr. Stephen Uden M.D., MBBS	Co-Founder, President, CEO & Director
Mr. Jonathan I. Lieber M.B.A.	CFO & Treasurer
Dr. Steven W. Ryder F.A.C.P, M.D.	Chief Medical Officer

FAQs

What is Rallybio Corp share price today?

Rallybio Corp share price today is $8.75 as on March 25, 2026 at 9:38 pm IST. Rallybio Corp share today touched a day high of $9 and a low of $8.76.

What is the 52 week high and 52 week low for Rallybio Corp share?

Rallybio Corp share touched a 52 week high of $11.49 on March 3, 2026 and a 52 week low of $1.76 on April 8, 2025. Rallybio Corp stock price today i.e. March 25, 2026 at 9:38 pm IST is trending at $8.75,which is 23.85% down from its 52 week high and 396.93% up from its 52 week low.

What is Rallybio Corp's market capitalisation today?

Rallybio Corp market capitalisation is $0.00T as on March 25, 2026 at 9:38 pm IST.

How to invest in Rallybio Corp Stock (RLYB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Rallybio Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rallybio Corp Shares that will get you 0.1714 shares as per Rallybio Corp share price of $8.75 per share as on March 25, 2026 at 9:38 pm IST.

What is the minimum amount required to buy Rallybio Corp Stock (RLYB) from India?

Indian investors can start investing in Rallybio Corp (RLYB) shares with as little as ₹94.138 or $1 (as of March 25, 2026 at 9:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹941.38 in Rallybio Corp stock (as per the Rupee-Dollar exchange rate as on March 25, 2026 at 9:40 pm IST). Based on Rallybio Corp share’s latest price of $8.75 as on March 25, 2026 at 9:38 pm IST, you will get 1.1429 shares of Rallybio Corp. Learn more about fractional shares .